Nishimura JI, Usuki K, Ramos J, Ichikawa S, et al. Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study. Br J Haematol 2022;198:e46-e50.
PMID: 35608260